"Haloperidol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
| Descriptor ID |
D006220
|
| MeSH Number(s) |
D02.522.352.506
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Haloperidol".
Below are MeSH descriptors whose meaning is more specific than "Haloperidol".
This graph shows the total number of publications written about "Haloperidol" by people in this website by year, and whether "Haloperidol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Haloperidol" by people in Profiles.
-
Dopamine Antagonists in ICU Delirium. N Engl J Med. 2018 12 27; 379(26):2569-2570.
-
Subtypes of pediatric delirium: a treatment algorithm. Psychosomatics. 2007 May-Jun; 48(3):253-7.
-
Milieu management of a child with bipolar illness. J Child Adolesc Psychiatr Nurs. 2005 Jul-Sep; 18(3):113-5.
-
Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use. Expert Opin Drug Saf. 2003 Nov; 2(6):543-7.
-
Torsade de pointes associated with the administration of intravenous haloperidol. Am J Ther. 2003 Jan-Feb; 10(1):58-60.
-
Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol. 1992 Dec; 15(6):488-500.
-
Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53.
-
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300.
-
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7.
-
Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin Neuropharmacol. 1989 Oct; 12(5):425-34.